1 |
Bowman, T., Garcia, R., Tukson, J., Jove, R. STATs in oncogenesis. Oncogene. 19: 2474-2488, 2000.
DOI
ScienceOn
|
2 |
Aggarwal, B.B., Sethi, G., Ahn, K.S., Sandur, S.K., Pandey, M.K., Kynnmakkara, A.B., Sung, B., Ichikawa, H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 1091: 151-169, 2006.
DOI
ScienceOn
|
3 |
Koh, M., Spivak-Kroizman, TR., Powis, G. HIF-1 regulation: not so easy come, easy go. Trend Biochem Sci. 33: 526-534, 2008.
DOI
ScienceOn
|
4 |
Jung, J.E., Lee, H.G., Cho, I.H., Chung, D.H., Yoon, S.H., et al. STAT3 is a potential modulator of HIF-1 mediated VEGF expression in human renal carcinoma cells. FASEB J. 19: 1286-1298, 2005.
|
5 |
Jung, J.E., Kim, H.S., Lee, C.S., Shin, Y.J., Kim, Y.N., et al. STAT3 inhibits the degradation of HIF-1alpha by pVHLmediated ubiquitination. Exp Mol Med 40: 479-485, 2008.
DOI
ScienceOn
|
6 |
Cheng, T.O. Cardiovascular effects of Danshen. Int J Cardiol. 121: 9-22, 2007.
DOI
ScienceOn
|
7 |
Zhou, L., Zuo, Z., Chow, M.S. Danshen : an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J clin Pharmacol. 45: 1345-1359, 2005.
DOI
ScienceOn
|
8 |
Wojcikowski, K., Johnson, DW., Gobe, G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med. 147: 160-166, 2006.
DOI
ScienceOn
|
9 |
Yu, X.Y., Lin, S.G., Chen, X., Zhou, Z.W., Liang, J., Duan, W., et al.Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier. Curr Drug Metab. 8: 365-378, 2007.
DOI
ScienceOn
|
10 |
Liu, J., Shen, H.M., Ong, C.N.. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG(2) cells. Cancer Lett. 153: 85-93, 2000.
DOI
ScienceOn
|
11 |
Shin, D.S., Kim, H.N., Shin, K.D., Yoon, Y.J., Kim, S.J., Han, D.C., et al. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res. 69: 193-202, 2009.
DOI
ScienceOn
|
12 |
Chen, W., Luo, Y., Liu, L., Zhou, H., Xu, B., Han, X., et al. Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation. Cancer Prev Res 3: 1015-1025, 2010.
DOI
ScienceOn
|
13 |
Niu, G., Wright, KL., Huang, M., Song, L., Haura, E, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 21: 2000-2008, 2002.
DOI
ScienceOn
|
14 |
Zhu, C., Qi, X., Chen, Y., Sun, B., Dai, Y., Gu, Y. PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol. 137(11):1587-1594, 2011.
DOI
ScienceOn
|
15 |
Kim, S.H., Ahn, K.S., Jeong, S.J., Kwon, T.R., Jung, J.H., et al. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Eur J Pharmacol. 654: 10-16, 2011.
DOI
ScienceOn
|
16 |
Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M., Michiels, C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem. 278(33):31277-31285, 2003.
DOI
ScienceOn
|
17 |
Du, J., Xu, R., Hu, Z., Tian, Y., Zhu, Y., Gu, L., Zhou, L. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1 expression in MCF-7 breast cancer cells.PLoS one. 6(9):e 25213, 2011.
DOI
|
18 |
Wei, D., Le, X., Zheng, L., Wang, L., Frey, JA., et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 22: 319-329, 2003.
DOI
ScienceOn
|